Lipopolysaccharide Binding Protein (LBP) Antibody (PE)

Este producto es parte de LBP - Lipopolysaccharide binding protein
Product Graph
611€ (200 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Lipopolysaccharide Binding Protein (LBP) Antibody (PE)
category
Primary Antibodies
provider
Abbexa
reference
abx274620
tested applications
WB, IHC, IF/ICC

Description

Lipopolysaccharide Binding Protein (LBP) Antibody (PE) is a Rabbit Polyclonal antibody conjugated to PE against Lipopolysaccharide Binding Protein (LBP).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Lipopolysaccharide Binding Protein (LBP)
Host
Rabbit
Reactivity
Rat
Recommended Dilution
WB: 0.5-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
PE
Isotype
IgG
Purification
Purified by antigen-specific affinity chromatography.
Size 1
200 µl
Size 2
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
BPIFD2,BPI Fold Containing Family D,LPS-Binding Protein 3
Background
Antibody anti-LBP
Status
RUO

Descripción

LBP is an acute-phase protein produced mainly by the liver in response to infections and inflammation It plays a crucial role in innate immunity by binding to lipopolysaccharides (LPS) from the outer membrane of Gram-negative bacteria and delivering them to CD14 and Toll-like receptor 4 (TLR4) complexes on immune cells This process triggers signaling pathways that lead to the production of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, initiating immune defense against bacterial infections Elevated LBP levels are observed in sepsis, systemic inflammatory response syndrome (SIRS), and chronic inflammatory diseases Dysregulation of LBP contributes to endotoxemia, where excessive immune activation results in tissue damage and organ failure It is a valuable biomarker for assessing infection severity and therapeutic outcomes in sepsis and inflammatory conditions

Related Products

EB0197

Bovine LBP (Lipolysaccharide binding protein) ELISA Kit

Ver Producto
EGS0002

Goat/Sheep LBP (Lipopolysaccharide-binding protein) ELISA Kit

Ver Producto
EH1560

Human LBP (Lipopolysaccharide-binding protein) ELISA Kit

Ver Producto